 |
   Thursday, July 2, 2009
Hyperion Therapeutics Raises $60 Million Series C FundingFinancing to fund specialty pharmaceutical company's Phase III clinical program for urea cycle disorders and Phase II study in low grade hepatic encephalopathy.picoChip Helping to Drive Femtocell Adoption Across EuropeVodafone UK is launching commercial femtocell service on July 1 based on picoChip's chipset, making it the first operator to offer the tiny home base stations to consumers in Europe.AOL Buys Online Social Network, Going Inc.Acquisition is part of a broader strategy to build AOL's position in the online advertising market.Aveo Kidney Cancer Drug, Challenging Pfizer and Bayer, Passes Important TestBiopharmaceutical company, Aveo releases important data that suggests it may by on its way to developing a better way to cut off blood supply to tumors.Acme Packet Acquires CovergenceLeader in session border control solutions, Acme Packet (Nasdaq: APQT) has acquired privately-held Covergence. |
  At Highland Capital Partners, we have always been focused on one goal: to help great people build great companies. Since our inception in 1988, we have invested in over 200 seed, early and growth stage companies – 90 of which have gone public or been acquired to date. We emphasize a team-oriented approach in providing the right mix of strategic guidance, hands-on leadership and deep industry domain expertise in helping entrepreneurs and their teams to become market-leading organizations.
"There are certain things that you only know when you've been through them. As an early investor in Ocular, Highland's industry knowledge, experience and guidance were absolutely central to the success of our business."
Ed Kennedy Former CEO Ocular Networks |
 |
